Data / Form D filings / Laurentide Therapeutics Inc.
Laurentide Therapeutics Inc.: Form D filing
Laurentide Therapeutics Inc., a pharmaceuticals company in Atlanta, GA, filed a Form D with the SEC in 2026. The latest, on September 28, 2026, reports $99,999 sold of a $100,000 offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2525 PEACHTREE RD #27, Atlanta, GA, 30305
- Phone
- (404) 680-1486
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2157396
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | New notice | $100,000 | $99,999 | $1 | 7 | Aug 20, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Horace Nalle | Executive Officer, Director |
Other pharmaceuticals companies in Georgia that filed recently
- LifeCyte Innovations, Inc. $1 million · Aug 20, 2026
Every Form D from the week of Sep 28, 2026 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Laurentide Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.